A Phase 1b Window of Opportunity Study to Investigate Mechanisms of Actions of Novel Therapeutic Agents in Patients With Resectable Solid Tumor Malignancies

Trial Profile

A Phase 1b Window of Opportunity Study to Investigate Mechanisms of Actions of Novel Therapeutic Agents in Patients With Resectable Solid Tumor Malignancies

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 24 May 2018

At a glance

  • Drugs Epacadostat (Primary)
  • Indications Solid tumours
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 17 Apr 2018 Planned initiation date changed from 1 Mar 2018 to 1 May 2018.
    • 22 Mar 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top